From: Nestin and CD133: valuable stem cell-specific markers for determining clinical outcome of glioma patients
5-year survival rate
TYPE
Total N
n
Percent (%)
p
Nestin
0
22
19
86.4
< 0.01
1+~2+
68
36
52.9
3+
35
7
20.0
CD133
27
81.5
64
31
48.4
34
20.6